{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:49:09Z","timestamp":1761061749313,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jinf.2022.11.022","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T20:21:07Z","timestamp":1669839667000},"page":"154-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-7137","authenticated-orcid":false,"given":"Huzaifa Ahmad","family":"Cheema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mobin Teymouri","family":"Athar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abia","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-6420","authenticated-orcid":false,"given":"Rehmat Ullah","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-218X","authenticated-orcid":false,"given":"Jaffer","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5353-2324","authenticated-orcid":false,"given":"Prasun K","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.11.022_bib0001","article-title":"Efficacy and safety of Paxlovid for COVID-19:a meta-analysis","author":"Qian","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.022_bib0002","article-title":"Minimum manufacturing costs, national prices, and estimated global availability of new repurposed therapies for Coronavirus Disease 2019","volume":"9","author":"Junzheng","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.022_bib0003","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2022.05.024","article-title":"Efficacy and safety of molnupiravir for COVID-19 patients","volume":"102","author":"Maurish","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.022_bib0004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gutjnl-2022-326952","article-title":"Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial","volume":"71","author":"Brennan Christina","year":"2022","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jinf.2022.11.022_bib0005","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1136\/gutjnl-2020-323668","article-title":"Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study","volume":"70","author":"Jiandong","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jinf.2022.11.022_bib0006","first-page":"e22404","article-title":"Efficacy of oral famotidine in patients hospitalized with severe acute respiratory syndrome Coronavirus 2","volume":"14","author":"Suraksha","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jinf.2022.11.022_bib0007","article-title":"The efficacy of famotidine in improvement of outcomes in hospitalized COVID-19 patients: a phase III randomised clinical trial","author":"Reza","year":"2021","journal-title":"Res Sq"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.022_bib0008","doi-asserted-by":"crossref","first-page":"692","DOI":"10.14309\/ajg.0000000000001153","article-title":"Comparative effectiveness of famotidine in hospitalized COVID-19 patients","volume":"116","author":"Azza","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2022.11.022_bib0009","article-title":"Efficacy of various treatment therapies on patient related outcome in hospitalized COVID-19 patients \u0336 a retrospective study","volume":"25","author":"Farhana","year":"2022","journal-title":"J Med Sci"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.022_bib0010","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.14309\/01.ajg.0000778736.01714.cd","article-title":"S1301 a retrospective review: famotidine use is not associated with improved outcomes in hospitalized patients with COVID-19","volume":"116","author":"Eugene","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.022_bib0011","doi-asserted-by":"crossref","first-page":"S668","DOI":"10.14309\/01.ajg.0000779364.64867.ec","article-title":"S1458 famotidine versus pantoprazole use and clinical outcomes in patients hospitalized with COVID-19: a retrospective study","volume":"116","author":"Justin","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jinf.2022.11.022_bib0012","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/j.gastro.2020.10.011","article-title":"Famotidine use is not associated with 30-day mortality: a coarsened exact match study in 7158 hospitalized patients with Coronavirus Disease 2019 from a large healthcare system","volume":"160","author":"Samrat","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.022_bib0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-021-00689-y","article-title":"Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients","volume":"6","author":"Cameron","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.jinf.2022.11.022_bib0014","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.27375","article-title":"The association between famotidine and in-hospital mortality of patients with COVID-19","volume":"94","author":"Toshiki","year":"2022","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.022_bib0015","article-title":"Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: recommendations for future research targets","volume":"16","author":"Fatemeh","year":"2022","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.022_bib0016","first-page":"9","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","volume":"34","author":"Kritas","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"10.1016\/j.jinf.2022.11.022_bib0017","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1053\/j.gastro.2020.05.053","article-title":"Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study","volume":"159","author":"Freedberg","year":"2020","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jinf.2022.11.022_bib0018","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.14309\/ajg.0000000000000832","article-title":"Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19","volume":"115","author":"Mather Jeffrey","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jinf.2022.11.022_bib0019","article-title":"Effect of famotidine on hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"16","author":"Leonard","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jinf.2022.11.022_bib0020","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1007\/s10620-021-06872-z","article-title":"Does famotidine reduce the risk of progression to severe disease, death, and intubation for COVID-19 patients? A systemic review and meta-analysis","volume":"66","author":"Chenyu","year":"2021","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:27Z","timestamp":1759008987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0163445322006831"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.022","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}